Trademark Overview
On Wednesday, November 12, 2025, a trademark application was filed for ULTRAHITMAB with the United States Patent and Trademark Office. The USPTO has given the ULTRAHITMAB trademark a serial number of 79441828. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, January 22, 2026. This trademark is owned by Zhuhai Trinomab Pharmaceutical Co., Ltd.. The ULTRAHITMAB trademark is filed in the Pharmaceutical Products, Advertising, Business and Retail Services, and Computer & Software Services & Scientific Services categories with the following description:
Drugs for medical purposes; pharmaceutical preparations; biological preparations for medical purposes; vaccines; medicines for human purposes; diagnostic preparations for medical purposes; dietetic substances adapted for medical use; protein supplements for animals; absorbent cotton.
Commercial administration of the licensing of the goods and services of others; presentation of goods on communication media, for retail purposes; advertising; retail services for pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale services for pharmaceutical, veterinary and sanitary preparations and medical supplies; marketing.
Technological research; chemical analysis; chemistry services; medical research; laboratory services for biomanufacturing; computer programming; providing online non-downloadable computer software; rental of scientific microscopes; clinical trials.
